Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
3.12
+ 0.05 (+1.63%)
Day High: 3.38
Day Low:  2.91
Volume:    9,148,890
4:00 PM ET on Feb 17, 2017

Delayed at least 20 minutes.